Lamotrigin Genericon

Lamotrigine, the active ingredient in Lamotrigin Genericon, is an Anticonvulsant presented as an oral tablet for oral use. It is used to treat epilepsy and to stabilize mood in bipolar disorder, primarily in adult patients.

GNH USA supplies Lamotrigin Genericon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides batch‑tested product for global distribution, manufactured under GMP conditions and shipped with full regulatory documentation.

Lamotrigine is an anticonvulsant that modulates neuronal excitability in seizure disorders and mood stabilization.

- Partial seizures: Decreases seizure frequency in focal onset seizures. - Generalized seizures: Controls tonic‑clonic seizures as part of combination therapy. - Bipolar disorder: Provides maintenance therapy to prevent recurrence of mood episodes and stabilize mood swings.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: Transient sensation of light‑headedness. - Headache: Mild to moderate intensity. - Nausea: Often mild and transient. - Rash: Typically maculopapular, may be pruritic. - Blurred vision: Temporary visual disturbances. - Fatigue: Generalized tiredness.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: Severe skin reaction requiring immediate discontinuation. - Toxic epidermal necrolysis: Life‑threatening skin detachment. - Blood dyscrasias: Aplastic anemia, agranulocytosis. - Hepatic failure: Rare but serious liver injury. - Suicidal thoughts: Emerging mood changes or ideation. - Severe skin reactions: Drug reaction with eosinophilia and systemic symptoms (DRESS).

When prescribing lamotrigine, clinicians should consider several safety measures.

- Dose adjustments: Follow prescriber guidance, especially during initiation and when co‑administered with enzyme‑modifying drugs. - Pregnancy: Risk category unknown; discuss potential benefits and risks with the patient. - Renal impairment: Monitor renal function and adjust dose if necessary. - Hepatic impairment: Use caution and consider dose modification. - Skin reactions: Discontinue immediately if a rash develops, and evaluate for severe cutaneous adverse reactions. - Store at ambient temperature: Keep in the original pack, protect from moisture and direct sunlight.

Lamotrigine interacts with several medicines that can alter its plasma concentration.

Major Interactions (Avoid): - Valproate: Increases lamotrigine levels, raising risk of toxicity. - Carbamazepine: Decreases lamotrigine levels, reducing efficacy. - Phenytoin: Lowers lamotrigine concentrations. - Oral contraceptives: Elevate lamotrigine clearance, requiring dose adjustment. - Strong enzyme inducers (e.g., rifampin): Reduce lamotrigine exposure.

Moderate Interactions (Monitor Closely): - Serotonergic agents: Potential for serotonin syndrome when combined. - Other antiepileptics (e.g., phenobarbital): May require therapeutic monitoring. - NSAIDs: May modestly increase lamotrigine levels. - Alcohol: Can enhance central nervous system depression. - Antidepressants (e.g., SSRIs): Observe for additive CNS effects.